Lotus Pharmaceutical Co. Ltd.

Lotus Pharmaceutical Co., Ltd., a Taiwanese subsidiary of Alvogen, specializes in high‑margin generics for oncology, CNS, cardiovascular, women's health, and obesity, and offers CRO, biotech consulting, and clinical device retail, positioning it for expansion in emerging markets.

Headquarters: Taiwan (TWN)

Lotus Pharmaceutical Co. Ltd. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
1795 Lotus Pharmaceutical Co. Ltd.
Cap: 84.6B | P/E: 17.9
EQUITY TAI TWD TW0001795003 Active
📈
Home Login